Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIMI Regulatory News (IMI)

Share Price Information for IMI (IMI)

Share Price is delayed by 15 minutes
Get Live Data
2,958.00    24.00 (0.82%)
Bid:
2,970.00
Ask:
2,972.00
Spread: 2.00 (0.067%)
Market Cap: £7.01b
IMI Live PriceLast checked at - London Stock Exchange

Intraday IMI Share Chart

Executive Committee change

22 Jan 2018 07:00

RNS Number : 4559C
IMI PLC
22 January 2018
 

22 January 2018

Executive Committee change

 

IMI plc (the "Group" or "IMI") announces the following changes to its Executive Committee.

Peter Spencer, Divisional Managing Director of IMI Hydronic Engineering and a member of the Executive Committee, has left the Group. An external search process to identify his successor is underway.

In the interim Phil Clifton, who recently joined IMI, will lead the Hydronic Engineering division as Interim Managing Director, overseen by Mark Selway, until a permanent Divisional Managing Director is appointed. Phil will also become a member of IMI's Executive Committee.

Phil has extensive commercial experience in the engineering sector. Previously he was Chief Executive of Signum Technology, the private equity backed specialist engineering group focused on flow control sectors. Prior to that he spent nearly seven years with The Weir Group PLC where he was Divisional Managing Director of the company's Power & Industrial division between 2007 and 2011. With a proven track record of driving significant growth, particularly in challenging market environments, Phil's skills will help us to capitalise on the Division's strong foundations and increase focus on its commercial opportunities.

Mark Selway, Chief Executive of IMI, commented "On behalf of the Board and the Executive Committee I would like to thank Peter for all his hard work and dedication since he joined IMI over seven years ago. He has made a significant contribution to the business and, in particular, he has helped transform the Hydronic division into a more focused and efficient organisation. Furthermore, he has overseen the creation of a number of new product ranges. We continue to execute the existing strategy for Hydronic Engineering, with a focus on opportunities for accelerated growth."

Preliminary results announcement

As previously advised, the Group's preliminary results announcement for the full year ended 31 December 2017, will be issued on 2 March 2018.

Expectations in relation to the Group's 2017 full year results, as outlined at the time of the November 2017 Interim Management Statement, remain unchanged, albeit the results from the IMI Hydronic Engineering division are likely to be lower than previously anticipated.

Enquiries to:

John Dean

IMI

Tel: +44 (0)121 717 3712

Suzanne Bartch / Gayden Metcalfe

Teneo Blue Rubicon

Tel: +44 (0)203 757 9239

 

Notes to editors

IMI plc

IMI plc, the specialist engineering company, designs, manufactures and services highly engineered products that control the precise movement of fluids. IMI has manufacturing facilities in more than 20 countries and operates a global service network. The Company is listed on the London Stock Exchange. Further information is available at www.imiplc.com.

 

IMI plc is registered in England No. 714275. Its legal entity identifier ('LEI') number is 2138002W9Q21PF751R30.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSFDFAUFASEIF
Date   Source Headline
21st Apr 202211:50 amRNSHolding(s) in Company
14th Apr 202212:16 pmRNSDirector/PDMR Shareholding
14th Apr 202212:15 pmRNSDirector/PDMR Shareholding
14th Apr 202212:12 pmRNSDirector/PDMR Shareholding
8th Apr 20223:18 pmRNSDirector/PDMR Shareholding
8th Apr 20223:15 pmRNSDirector/PDMR Shareholding
8th Apr 20223:07 pmRNSDirector/PDMR Shareholding
8th Apr 20223:00 pmRNSDirector/PDMR Shareholding
8th Apr 20222:53 pmRNSDirector/PDMR Shareholding
1st Apr 202210:39 amRNSTotal Voting Rights
31st Mar 20224:04 pmRNSDirector/PDMR Shareholding
31st Mar 20229:17 amRNSHolding(s) in Company
30th Mar 20226:03 pmRNSDirector/PDMR Shareholding
30th Mar 20226:02 pmRNSDirector/PDMR Shareholding
30th Mar 20225:58 pmRNSDirector/PDMR Shareholding
30th Mar 20225:57 pmRNSDirector/PDMR Shareholding
30th Mar 20225:53 pmRNSDirector/PDMR Shareholding
30th Mar 20225:49 pmRNSDirector/PDMR Shareholding
30th Mar 20225:48 pmRNSDirector/PDMR Shareholding
25th Mar 20224:21 pmRNSAnnual Financial Report
22nd Mar 20225:32 pmRNSDirector/PDMR Shareholding
22nd Mar 20225:31 pmRNSDirector/PDMR Shareholding
22nd Mar 20225:31 pmRNSDirector/PDMR Shareholding
22nd Mar 20225:31 pmRNSDirector/PDMR Shareholding
22nd Mar 20225:30 pmRNSDirector/PDMR Shareholding
9th Mar 20224:52 pmRNSDirector/PDMR Shareholding
9th Mar 20224:51 pmRNSDirector/PDMR Shareholding
9th Mar 20224:49 pmRNSDirector/PDMR Shareholding
8th Mar 20223:09 pmRNSHolding(s) in Company
7th Mar 20222:24 pmRNSDirector/PDMR Shareholding
1st Mar 20225:37 pmRNSDirector/PDMR Shareholding
1st Mar 202211:00 amRNSTotal Voting Rights
25th Feb 20227:00 amRNSPreliminary results, year ended 31 December 2021
10th Feb 202210:53 amRNSHolding(s) in Company
9th Feb 20225:20 pmRNSDirector/PDMR Shareholding
9th Feb 20225:19 pmRNSDirector/PDMR Shareholding
9th Feb 20225:15 pmRNSDirector/PDMR Shareholding
1st Feb 202211:25 amRNSTotal Voting Rights
25th Jan 20223:27 pmRNSHolding(s) in Company
12th Jan 20222:04 pmRNSDirector/PDMR Shareholding
12th Jan 20222:01 pmRNSDirector/PDMR Shareholding
12th Jan 20221:58 pmRNSDirector/PDMR Shareholding
12th Jan 20221:54 pmRNSDirector/PDMR Shareholding
4th Jan 20224:59 pmRNSBlock listing Interim Review
4th Jan 202211:55 amRNSTotal Voting Rights
20th Dec 20217:00 amRNSCompletion of Adaptas Solutions acquisition
15th Dec 20214:53 pmRNSDirector/PDMR Shareholding
15th Dec 20214:51 pmRNSDirector/PDMR Shareholding
15th Dec 20214:48 pmRNSDirector/PDMR Shareholding
15th Dec 20214:37 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.